How does Sitagliptin compare to GLP-1 receptor agonists in reducing inflammation, and what are the implications for managing diabetes-related complications?
Sunil JoshiExplorer
How does Sitagliptin compare to GLP-1 receptor agonists in reducing inflammation?
Share
Sitagliptin and GLP-1 receptor agonists both improve glycemic control, but GLP-1s may offer superior reduction in inflammation. This can be crucial in managing complications like cardiovascular disease in diabetes patients.